title: Discussion: a fresh look at monoamine oxidase inhibitors for depression.
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Cohen
authors.forename: David A
authors.initials: DA
authors.lastname: Sclar
authors.forename: Larry
authors.initials: L
authors.lastname: Culpepper
authors.forename: David A
authors.initials: DA
authors.lastname: Flockhart
authors.forename: Robert M A
authors.initials: RM
authors.lastname: Hirschfeld
authors.forename: Michael E
authors.initials: ME
authors.lastname: Thase
authors.forename: Chad M
authors.initials: CM
authors.lastname: VanDenBerg
mesh_terms: D000279:Administration, Cutaneous; D000284:Administration, Oral; D000465:Algorithms; D000928:Antidepressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003866:Depressive Disorder / Q000188:drug therapy*; D061218:Depressive Disorder, Treatment-Resistant / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D055118:Medication Adherence / Q000523:psychology; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D017211:Treatment Failure
chemical_list: D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors